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Background: Hemodynamic derangement during off-pump coronary artery bypass surgery (OPCAB) is mainly 
attributed to impaired filling and diastolic dysfunction. An elevated ratio of the mitral velocity to the early-diastolic 
velocity of the mitral annulus (E/e’ > 15) is a relatively new indicator of diastolic function, and this was reported 
to be associated with impaired hemodynamics during OPCAB. We investigated the efficacy of milrinone on the 
perioperative hemodynamics and short term outcomes of patients with an E/e’ > 15 and who underwent OPCAB.
Methods: The patients were randomly allocated into either group C (control, n = 31) or group M (n = 31) and they 
were treated with the same amount of either normal saline or milrinone (0.5 μg/kg/min) without bolus loading 
after completion of internal mammary artery harvest until the end of operation. Hemodynamic measurements 
were recorded after the induction of anesthesia (T1), 5 min after starting each distal anastomosis of the left anterior 
descending artery (T2), left circumflex artery (T3) and right coronary artery (T4), and 5 min after sternum closure (T5).
Results: The mixed venous oxygen saturation (SvO2) was lower through T2-T4 compared to the baseline value 
in both groups, while the degree of the decrease was significantly less in group M than that in group C. The other 
hemodynamic variables, the operative data and the postoperative outcomes were similar between the two groups.
Conclusions: Intraoperative infusion of milrinone did not significantly improve the perioperative hemodynamics 
and the subsequent short term outcomes for the patients with preexisting diastolic dysfunction as represented by 
an elevated E/e’ value, although it reduced the degree of decrease of the SvO2 during OPCAB. (Korean J Anesthesiol 
2011; 60: 185-191)
Key Words:  Diastolic dysfunction, E/e’, Milrinone, Off-pump coronary artery bypass surgery, Perioperative 
hemodynamics.
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Introduction
    Multivessel off-pump coronary artery bypass graft surgery 
(OPCAB) has proven to be a practicable and safe alternative to 
on-pump coronary artery bypass graft surgery (CABG) since the 
technical improvements and advances of stabilization devices 
have facilitated the comparable safety and early graft patency 
of OPCAB [1]. Yet displacement of the heart for exposing 
the grafting site during OPCAB can result in hemodynamic 
derangement, which is mainly attributed to impaired filling 
and diastolic dysfunction [2]. Thus, patients with pre-existing 
diastolic dysfunction would theoretically be more prone to 
experience significant hemodynamic deterioration when 
undergoing OPCAB.
    Among the various variables affecting the diastolic function, 
the ratio of the early transmitral flow velocity to the early 
diastolic velocity of the mitral annulus (E/e’) is a relatively new 
indicator of the diastolic function and it is well correlated with 
the left ventricular filling pressure [3]. In numerous studies, 
an E/e’ greater than 15 has been used to accurately detect an 
elevated left ventricular filling pressure [3,4]. It was reported 
that patients with an elevated E/e’ were more prone to undergo 
a reduction of the cardiac index (CI) and the mixed venous 
oxygen saturation (SvO2) during OPCAB [5].
    Milrinone is a phosphodiesterase III inhibitor and it is a non-
catecholamine drug that acts independently of β-adrenergic 
receptors and the plasma catecholamine concentrations [6]. It 
does not significantly increase myocardial oxygen consumption 
[7] and it leads to lower myocardial oxygen consumption than 
is associated with the use of dobutamine [8]. Milrinone also 
has a direct vasodilating effect on arterial coronary bypass 
grafts [9] and it increases the grafted mammary artery flow 
after coronary artery bypass grafting [10]. When performing 
OPCAB, the administration of milrinone during the operation 
reduced the extent of the decrease of the cardiac index and the 
extent of mitral regurgitation [11-13]. Furthermore, milrinone 
has been suggested to improve the diastolic function as 
well as the systolic function [14-16]. Thus, we investigated 
whether intraoperatively infused milrinone would improve 
the intraoperative hemodynamics in patients with diastolic 
dysfunction, as represented by an elevated E/e’ value, and who 
are undergoing OPCAB.
Materials and Methods
    Those patients scheduled for OPCAB between January 
and December 2009 were enrolled after receiving approval 
from our Institutional Review Board and obtaining informed 
written consent from the patients. The inclusion criteria 
were patients with an E/e’ value > 15, and this was measured 
1 day before elective OPCAB. The exclusion criteria were 
concomitant systolic dysfunction (a left ventricular ejection 
fraction less than 40%) or mitral regurgitation ≥ Grade 2, an 
emergency operation and being involved in other studies. The 
E/e’ value was measured by a cardiologist using transthoracic 
echocardiography. From the apical four-chamber view, the 
early transmitral inflow velocity (E) was measured by pulsed-
wave Doppler with a sample volume of 1-2 mm, and the 
early-diastolic velocity of the mitral annulus (e’) was measured 
by pulsed-wave Doppler tissue imaging of the septal mitral 
annulus with a sample volume of 2-4 mm. Sixty-four patients 
who met the inclusion criteria were randomized into the two 
groups using computer-generated codes: those receiving 
intraoperative milrinone (group M) and those receiving normal 
saline (group C). The group assignment for each patient was 
sealed in sequentially numbered, opaque envelopes. These 
envelopes were opened after induction of anesthesia and a 
nurse who is not involved in the anesthesia and postoperative 
care of the patients prepared milrinone or saline solution 
according to the group assignment. The patient characteristics 
were similar between the groups, except for the preoperative 
 Table 1. Patients’ Characteristics
Group C
(n = 31)
Group M
(n = 31)
Age (yr)
Height (cm)
Weight (kg)
Gender (M/F)
Preoperative Cr (mg/dl)
COPD
Diabetes
Hypertension
History of CVA
CHF (NYHA ≥ III)
Preoperative Echocardiography
    LVEF (%)
    Akinesia
    Thinning
    E/e’
Lt main disease
Acute coronary syndrome
Preoperative medication
    β-blocker
    Calcium channel blocker
    ARB
    ACEi
    Diuretics
65.7 ± 7.9
162.9 ± 10.2
64.5 ± 9.4
21/10
1.50 ± 1.74
  7
20
23
  3
10
51.5 ± 16.7
16
  5
21 ± 8
  8
22
25
11
  9
12
12
67.2 ± 7.6
159.9 ± 9.8
63.5 ± 10.5
14/17
1.60 ± 1.58
  3
17
22
  3
13
55.3 ± 15.3
10
  4
21 ± 6
10
20
  17*
17
10
11
    5*
Values are means ± SDs or the number of patients. Cr:serum 
creatinine, COPD: chronic obstructive pulmonary disease, CVA: 
cerebrovascular accident, CHF: congestive heart failure, NYHA: New 
York Heart Association, LVEF: left ventricular ejection fraction, E/e’: 
ratio of the mitral velocity to the early-diastolic velocity of the mitral 
annulus, ARB: angiotensin receptor blocker, ACEi: angiotensin 
converting enzyme inhibitor, *P < 0.05 versus Group C.
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medications (Table 1). More patients in the group C received 
β-blockers (P < 0.05) and diuretics (P < 0.05), preoperatively.
    All the patients were premedicated with 0.05-0.1 mg/kg of 
intramuscular morphine 1 h before operation. Before induction 
of general anesthesia, standard monitoring devices were 
applied, including a radial artery catheter and a pulmonary 
artery catheter (Swan-Ganz Combo CCO/SvO2, Edwards 
Lifesciences LLC, USA), which was inserted through the right 
internal jugular vein and connected to an analysis system 
(Vigilance, Edwards Lifesciences LLC, USA) for continuous 
monitoring of the CI and SvO2. Anesthesia was induced with 
intravenous midazolam (0.03-0.07 mg/kg) and sufentanil 
(1.5-2.0 μg/kg). Neuromuscular block was achieved by 
administering rocuronium (0.9 mg/kg) and this was maintained 
with a continuous infusion of vecuronium (1-2 μg/kg/min). 
The patients were intubated and mechanically ventilated with a 
tidal volume of 8 mg/kg and a positive end-expiratory pressure 
of 5 mmHg at a rate of 8-12 breaths/min. Maintenance of 
anesthesia was done with 0.8-1.5 vol% of sevoflurane in a 40% 
oxygen/air mixture and a continuous infusion of sufentanil 
(0.5-1.5 μg/kg/h). Isosorbide dinitrate 0.5 μg/kg/min was 
infused in all the patients.
    After induction of anesthesia, a transesophageal echocardio-
graphy probe was inserted to assess the global cardiac function 
and to detect newly developed regional wall motion abnor-
malities. Intravascular fluid was administered to maintain the 
pulmonary capillary wedge pressure (PCWP) between 8 and 
16 mmHg according to the baseline values before enucleation 
of the heart and after completion of grafting. After completion 
of harvesting the left internal mammary artery, the patients in 
group M received 0.5 μg/kg/min of milrinone intravenously 
until the end of the distal anastomosis, while the patients in 
group C received the same amount of saline intravenously for 
the same duration. During the period of heart displacement, 
crystalloid solution was infused at a fixed rate of 6 ml/kg/h, 
and the amount of blood lost and collected by a cell salvage 
device was replaced by an infusion of colloid solution. The 
blood salvaged by the cell salvage device was re-infused into 
the patient before the end of the surgery. During the period 
of heart displacement and grafting, a mean systemic arterial 
pressure (MAP) was maintained above 70 mmHg with using 
either a 5-10o Trendelenburg position or a norepinephrine 
(NE) infusion. In the case of a SvO2 < 60% for more than 10 
min, the development of mitral regurgitation ≥ Grade 3 with a 
concomitant increase in the mean pulmonary arterial pressure 
(MPAP) > 30 mmHg or both, an attending anesthesiologist 
could break the code and milrinone could be infused at his or 
her discretion. Allogenic-packed red blood cells (pRBCs) were 
transfused to maintain the hematocrit (Hct) level around 25% 
throughout the study period. The central temperature measured 
by a pulmonary artery catheter (PAC) was maintained above 
36oC with a warm mattress, a forced warm air blanket and 
a fluid warmer as necessary. Emergency cardiopulmonary 
bypass was performed when the MAP remained lower than 
50 mmHg with an elevated MPAP despite volume loading and 
drug treatment, there was a change in the ST segment more 
than 4 mm during the coronary artery anastomosis or there was 
ventricular fibrillation that did not respond to cardioversion.
    All the surgical procedures were performed by one surgeon. 
After a median sternotomy, the heart was displaced using post-
erior pericardial stitches, large gauze swabs and tissue stabilizer 
(Octopus, Medtronic Inc., USA). Vertical right pericardiotomy 
was also performed to minimize compression of the right 
ventricle. The sequence of grafting was first the left internal 
mammary artery was grafted to the left anterior descending 
coronary artery (LAD) and this is followed by grafting the left 
circumflex coronary artery (LCx) and the right coronary artery 
(RCA) by way of a composite Y graft consisting of a radial artery 
or saphenous vein with the left internal mammary artery. 
All the patients were transferred to the intensive care unit 
(ICU) after the surgery. The postoperative care of the patients, 
including decisions for extubation and discharge from the ICU, 
was conducted according to the standard ICU protocols of our 
institution by the ICU staff, which was not aware of the study 
groups of the patients.
    The assessed operative data was the number of grafts, the total 
distal graft reconstruction time, the amount of infused fluid, the 
urine output and transfusion, the amount of NE infused during 
grafting and the number of patients who needed intraoperative 
vasopressin use.
    The hemodynamic variables obtained from the PAC and 
arterial line were recorded 15 minutes after the induction of 
anesthesia (T1), 10 minutes after stabilizer application for 
LAD grafting (T2), at the time of LCx grafting (T3) and RCA 
grafting (T4) and 15 minutes after sternum closure (T5). The 
hemodynamic data included the SvO2, CI, HR, MAP, central 
venous pressure (CVP), MPAP and right ventricular ejection 
fraction (RVEF). The number of patients with any episode of 
CI < 2.0 L/min/m2 and/or SvO2 < 60% during distal grafting 
was recorded. In the ICU, the highest postoperative creatin 
kinase (CK)-MB value and the number of patients requiring 
inotropic support were recorded. The following postoperative 
complications during hospitalization were recorded; acute 
renal failure requiring dialysis, atrial fibrillation, myocardial 
infarction, stroke, acute kidney injury (serum creatinine 
elevation > 0.3 mg/dl or > 50% from the baseline), reoperation, 
infection and prolonged ventilation (> 48 h). The duration of 
the ICU stay and postoperative hospital stay and the mortality 
were also recorded.
    Twenty-seven patients were required in each group for 95% 
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power to detect a 0.5 L/min/m2 difference in the CI between 
the groups with a SD of 0.5 L/min/m2 and an α value of 0.05, 
and the sample size was set at 32 patients in each group when 
considering a 10% failure rate for data collection. All the data is 
expressed as means ± SDs or the number of patients. The data 
was analyzed using χ2 tests, Fisher’s exact test or independent 
t-tests as appropriate. The hemodynamic data was analyzed by 
repeated measures of ANOVA. Post-hoc tests were conducted 
with Bonferroni adjustment. The statistical analyses were 
performed using SAS 9.1.3 (Institute Inc., Cary, NC, USA). A P 
value < 0.05 was considered statistically significant.
Results
    One patient in group M was converted to emergency cardio-
pulmonary bypass due to hemodynamic instability and one 
patient in group C received milrinone infusion during distal 
LCx and RCA grafting due to an extremely lower SvO2 with 
concomitantly increased mitral regurgitation. A total of 62 
patients completed the study.
    The operative data, including the number of grafts, the total 
distal graft reconstruction time, the amount of NE infused 
during distal grafting, the number of patients requiring 
vasopressin, the hematocrit and the intraoperative input and 
output were not significantly different between the groups 
(Table 2).
    The baseline hemodynamic variables at T1 showed no 
differences between the groups. The SvO2 was significantly 
decreased at T2, T3 and T4 compared to the baseline value at 
T1 in both groups, but the degree of decrease in the SvO2 was 
significantly less in group M than that in group C (Table 3, P < 
0.05). The CI was reduced at T3 and T4, the CVP and MPAP were 
increased at T2, T3 and T4, the HR was increased at T4 and the 
RVEF was significantly decreased at T3, T4 and T5 compared to 
the baseline value at T1 in both groups (all P < 0.05). However, 
the degree of changes of the CI and the other hemodynamic 
variables, except the SvO2, were similar between the groups 
(Table 3). The number of patients with an episode of a CI less 
than 2.0 L/min/m2 were 19 in group C and 15 in group M (P > 
0.05), and the number of patients with a episode of a SvO2 less 
than 60% were 9 in group C and 4 in group M (P > 0.05).
    The highest postoperative CK-MB concentrations during the 
ICU stay and the number of patients requiring vasopressors 
Table 3. Hemodynamic Data
Group T1 T2 T3 T4 T5
SvO2 (%)
CI (L/min/m2)
HR (beats/min)
MAP (mmHg)
CVP (mmHg)
MPAP (mmHg)
RVEF (%)
Group C
Group M
Group C
Group M
Group C
Group M
Group C
Group M
Group C
Group M
Group C
Group M
Group C
Group M
77 ± 6
77 ± 5
2.7 ± 0.7
2.5 ± 0.4
64 ± 14
61 ± 10
69 ± 9
72 ± 10
8 ± 3
9 ± 3
18 ± 4
18 ± 5
34 ± 10
32 ± 7
68 ± 11
72 ± 9*
2.5 ± 0.5
2.5 ± 0.7
65 ± 10
67 ± 10
70 ± 4
71 ± 7
10 ± 3
11 ± 3
21 ± 4
23 ± 6
29 ± 5
30 ± 7
64 ± 8
70 ± 8*
1.9 ± 0.4
2.1 ± 0.5
66 ± 10
67 ± 15
69 ± 7
69 ± 6
10 ± 3
10 ± 3
21 ± 4
21 ± 5
26 ± 8
27 ± 7
67 ± 8
71 ± 8*
2.0 ± 0.4
2.1 ± 0.3
66 ± 9
72 ± 11
71 ± 5
68 ± 7
11 ± 3
11 ± 3
21 ± 5
20 ± 6
27 ± 8
26 ± 8
71 ± 4
74 ± 6*
2.5 ± 0.4
2.6 ± 0.7
70 ± 11
74 ± 13
70 ± 11
69 ± 7
8 ± 2
8 ± 3
20 ± 4
18 ± 4
28 ± 6
30 ± 6
Values are means ± SDs. SvO2: mixed venous oxygen saturation, CI: cardiac index, HR:  heart rate, MAP: mean arterial pressure, CVP: central 
venous pressure, MPAP: mean pulmonary arterial pressure, RVEF: right ventricular ejection fraction. T1: 15 min after induction of anesthesia, 
T2: 10 min after applying stabilizer for left anterior descending coronary artery grafting, T3: left circumflex coronary artery grafting, T4: right 
coronary artery grafting, T5: 15 min after sternum closure. *P < 0.05 a significantly lesser degree of a decrease from T1 as compared to the value 
for Group C.
Table 2. Operative Data
Group C
(n = 31)
Group M
(n = 31)
Number of grafts (1/2/3/4/5)
Total graft reconstruction time (min)
NE infused during grafting (μg)
Intraoperative vasopressin use
Hematocrit (%)
    Post-induction
    Before LAD grafting
    After sternum closure
Input
    Crystalloid (ml)
    Colloid (ml)
    pRBC (ml)
    Salvaged blood (ml)
Urine output (ml)
0/3/14/12/2
33 ± 7
197 ± 110
21
32 ± 4
28 ± 4
27 ± 3
2,560 ± 658
1,255 ± 240
276 ± 322
213 ± 111
560 ± 321
0/7/18/5/1
31 ± 8
174 ± 105
20
31 ± 3
27 ± 3
26 ± 2
2,487 ± 899
1,235 ± 221
314 ± 333
253 ± 184
529 ± 465
Values are means ± SDs or the number of patients. NE: norepi-
nephrine, LAD: left anterior descending coronary artery, pRBC: 
packed red blood cells.
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and inotropic support during the ICU stay were not different 
between the groups (Table 4). The incidence of postoperative 
complications, the duration of the ICU and postoperative 
hospital stay and the mortality were not different between the 
groups (Table 4).
Discussion
    In this prospective randomized controlled trial of OPCAB, 
we investigated whether a preemptive intravascular infusion 
of milrinone would improve the intraoperative hemodynamics 
and short term postoperative outcomes in patients with an 
elevated E/e’ value, which implicated impaired diastolic 
function.
    Hemodynamic instability during distal anastomosis is the 
most serious problem during OPCAB surgery. The resultant 
myocardial dysfunction after displacing the heart during an 
OPCAB procedure is mainly diastolic dysfunction [2] and it 
is directly related to the postoperative outcomes. Lifting and 
tilting the heart in order to expose the posterior or lateral walls 
displace the atria below the corresponding ventricles, and 
the result is an increase in the atrial pressure and size [17], 
and thus, higher than normal filling pressures are required 
to maintain ventricular filling [18]. A vertical positioning 
of the heart induces distortions of the mitral and tricuspid 
annuli that may result in either stenosis or regurgitation of the 
corresponding valve [19]. In addition, application of a stabilizer 
device restricts the regional myocardial wall motion [20]. These 
changes contribute to a decrease in preload and stroke volume, 
resulting in a reduced CI, SvO2 and MAP, and especially during 
exposure of the posterior wall [2]. Thus, it could be expected 
that patients with diastolic dysfunction are at a risk of more 
severe hemodynamic deterioration.
    While the systolic function can easily be described by the 
LVEF, which is a commonly used indicator of systolic function, 
there are no definite variables to assess diastolic filling despite 
the well known importance of the diastolic function. The E/e’ 
value derived from tissue Doppler echocardiography has been 
recently demonstrated to be a relatively load-independent 
index, and this is well correlated well with the left ventricular 
filling pressures [3,4]. The E/e’ value is also considered a reliable 
index for diagnosing diastolic dysfunction. Because the e’ 
value reflects the rate of myocardial relaxation, E/e’ may be a 
precise variable that reflects a directly measured left ventricular 
end-diastolic pressure in terms of the diastolic function. The 
correlation of the E/e’ with LV filling has been validated in 
various conditions [3,4]. Increased morbidity and/or mortality 
after myocardial infarction were reported in patients with an 
elevated E/e’ value [21,22]. Further, the patients in a previous 
study with an E/e’ > 15 experienced more severe hemodynamic 
derangement during OPCAB in spite of the preserved systolic 
left ventricular function [5]. When performing OPCAB, it is 
thought that that improvement of the diastolic function in 
the patients with preoperative diastolic dysfunction, which is 
represented by an elevated E/e’, would be helpful to attenuate 
hemodynamic deterioration.
    Milrinone has been shown to improve cardiac performance 
in patients who are undergoing cardiac surgery and it facilitates 
weaning from cardiopulmonary bypass [23,24]. Previous studies 
on patients who are undergoing OPCAB demonstrated that 
milrinone infusion was beneficial to minimize the decrease of 
the CI and SvO2 [11,12]. It was also suggested that milrinone 
might improve the ventricular diastolic function in patients with 
congestive heart failure since ventricular relaxation, as well as 
contraction, is an energy-dependent process [14,15]. Yet several 
studies that have evaluated the lusitropic effect of milrinone 
in cardiac surgery have showed contradictory results. While 
milrinone administration after aortic declamping improved 
the diastolic function as assessed by acoustic quantification 
and the peak filling rate during coronary artery bypass surgery 
[16], it failed to demonstrate a favorable lusitropic effect in 
other studies [25-27]. Many factors might be associated with 
this controversy; differences in the type of underlying cardiac 
disease and operation, the varying degrees of preexisting 
diastolic dysfunction and the modality used to assess diastolic 
dysfunction. In this study, administration of milrinone did 
not significantly improve the CI and SvO2, which is unlike the 
previous studies, suggesting the lesser efficacy of milrinone 
in patients with preexisting diastolic dysfunction. The early 
studies that focused on patients with congestive heart failure 
have indicated that the lusitropic effect of milrinone also results 
Table 4. Postoperative Data 
Group C
(n = 31)
Group M
(n = 31)
Vasopressor in ICU
Inotropics in ICU
Highest postoperative CK-MB (ng/ml)
Postoperative complications
    Dialysis
    Atrial fibrillation
    Myocardial infarction
    Stroke
    Acute kidney injury
    Re-operation
    Infection
    Intubation > 48 h
ICU day
Hospital day
Mortality
12
6
9.8 ± 5.7
1
0
2
0
3
0
2
1
3.2 ± 1.6
19.1 ± 21.2
1
17
10
9.6 ± 8.1
3
1
1
1
4
2
3
3
5.1 ± 6.0
16.0 ± 7.0
1
Values are means ± SDs or the number of patients. ICU: intensive 
care unit.
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from the indirect effects caused by afterload reduction, as well 
as the direct effect of an improved active relaxation rate [28]. 
However, specific findings of a reduced afterload in terms of a 
decreased MAP or systemic vascular resistance or an increased 
cardiac output or the use of vasopressors were not observed in 
group M in this study, which may have been associated with 
the possibility of a lower blood concentration of milrinone. In 
this study, milrinone was infused at a rate 0.5 μg/kg/min, which 
was reported to increase the CO without causing systemic 
hypotension during OPCAB [29]. Despite that a significant 
hemodynamic effect of milrinone was reported to appear within 
30 minutes from the start of the infusion (without a bolus), the 
plasma concentration of a continuous infusion without a bolus 
reached the same level, at least after 1 h, as the concentration 
of an infusion after bolus injection [30]. Considering that an 
average of 20-30 min was required to start distal grafting after 
internal mammary artery harvesting, the plasma concentration 
of milrinone would not reach the concentration necessary 
to produce significant afterload reduction during distal 
anastomosis.
    Although the patients in group M showed a lesser decrease 
of the SvO2, the postoperative outcomes were not different 
between the groups. This could be partially explained by the 
fact that there was no difference in the number of patients with 
decreased CI or SvO2 below a critical level (CI < 2.0 L/min/m
2, 
SvO2 < 60%) between the groups, and the sample size of this 
study may not have been large enough to detect differences in 
relatively uncommon postoperative complications. The ICU 
stay of group M tended to be a little longer than that of group C, 
but there was one patient who stayed in the ICU for 34 days.
    There are several limitations in this study. First, we did not 
measure the diastolic function intraoperatively. Direct assess-
ment of the effect of milrinone on the systolic and diastolic 
heart function was not obtained and future studies should 
address this. Second, there were differences of the pre-
operative medication between the groups. More patients in 
group C were taking β-blockers. Although the preoperative 
use of β-blockers can result in intraoperative bradycardia and 
hypotension, the hemodynamic variables at post-induction 
showed no differences between the groups. Moreover, the effect 
of milrinone is independent of β-adrenergic receptor blockade 
[6], and so it is unlikely that the preoperative use of β-blockers 
has a significant influence on the effect of milrinone on the 
hemodynamics during grafting.
    In conclusion, for the patient with preexisting diastolic 
dysfunction as assessed by an elevated E/e’ value, a continuous 
infusion of milrinone without bolus loading was not beneficial 
to improve the hemodynamic variables during OPCAB and the 
short-term postoperative outcomes, although it reduced the 
extent of the decrease of the SvO2 during the operation.
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